The EluNIR Ridaforolimus Eluting Coronary Stent System optimizes conformability and uniformity and features the lowest metal footprint on the U.S. market1. EluNIR DES’s innovative engineering and unique WiZeCell™ design delivers…
- The Narrowest Strut Width (72 mm & 40 mm)
- The Lowest Metal Footprint (10%) on the market1
- Excellent conformability and uniform scaffolding
- Uniform drug distribution
The WiZeCell™ stent design combined with QualitySurface™ manufacturing contributes to the EluNIR® DES’s outstanding clinical results including a TLF of 5.4% at 12 months, and a TLF of 7.6% and late/very late stent thrombosis of 0.1% over 24 months.2
1. Medinol data on file. As compared to Synergy, Resolute Onyx, Xience, and Orsiro.
2.VLST 0.1%; 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS trials: Presented by Dr. D. Kandzari, TCT 2018..